|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Systematic review and meta-analysis of colon cleansing preparations in patients with inflammatory bowel disease显示文摘AIM To performed a systematic review and meta-analysis to determine any possible differences in terms of effectiveness, safety and tolerability between existing colon-cleansing products in patients with inflammatory bowel disease.METHODS Systematic searches were performed( January 1980-September 2016) using MEDLINE, EMBASE, Scopus, CENTRAL and ISI Web of knowledge for randomized trials assessing preparations with or without adjuvants, given in split and non-split dosing, and in high(> 3 L) or low-volume(2 L or less) regimens. Bowel cleansing quality was the primary outcome. Secondary outcomes included patient willingness-torepeat the procedure and side effects/complications.RESULTS Out of 439 citations, 4 trials fulfilled our inclusion criteria(n = 449 patients). One trial assessed the impact of adding simethicone to polyethylene glycol(PEG) 4 L with no effect on bowel cleansing quality, but a better tolerance. Another trial compared senna to castor oil, again without any differences in term of bowel cleansing. Two trials compared the efficacy of PEG high-volume vs PEG low-volume associated to an adjuvant in split-dose regimens: PEG low-dose efficacy was not different to PEG high-dose; OR = 0.84(0.37-1.92). A higher proportion of patients were willing to repeat low-volume preparations vs high-volume; OR = 5.11(1.31-20.0). CONCLUSION In inflammatory bowel disease population, PEG lowvolume regimen seems not inferior to PEG high-volume to clean the colon, and yields improved willingness-torepeat. Further additional research is urgently required to compare contemporary products in this population. | Sophie Restellini Omar Kherad Talat Bessissow Charles Ménard Myriam Martel Maryam Taheri Tanjani Peter L Lakatos Alan N Barkun | 2017 | World Journal of Gastroenterology2017，23，32： | 16 |
| 2 | Randomized trial in malignant biliary obstruction:Plastic vs partially covered metal stents显示文摘AIM:To compare efficacy and complications of par-tially covered self-expandable metal stent(pcSEMS)to plastic stent(PS)in patients treated for malignant,infrahilar biliary obstruction.METHODS:Multicenter prospective randomized clinical trial with treatment allocation to a pcWallstent(SEMS)or a 10 French PS.Palliative patients aged≥18,for infrahilar malignant biliary obstruction and a Karnofsky performance scale index>60%from 6 participating North American university centers.Primary endpoint was time to stent failure,with secondary outcomes of death,adverse events,Karnofsky performance score and short-form-36 scale administered on a three-monthly basis for up to 2 years.Survival analyses were performed for stent failure and death,with Cox proportional hazards regression models to determine significant predictive characteristics.RESULTS:Eighty-five patients were accrued over 37mo,42 were randomized to the SEMS group and 83patients were available for analyses.Time to stent failure was 385.3±52.5 d in the SEMS and 153.3±19.8 d in the PS group,P=0.006.Time to death did not differ between groups(192.3±23.4 d for SEMS vs211.5±28.0 d for PS,P=0.70).The only significant predictor was treatment allocation,relating to the time to stent failure(P=0.01).Amongst other measured outcomes,only cholangitis differed,being more common in the PS group(4.9%vs 24.5%,P=0.029).The small number of patients in follow-up limits longitudinal assessments of performance and quality of life.From an initially planned 120 patients,only 85 patients were recruited.CONCLUSION:Partially covered SEMS result in a longer duration till stent failure without increased complication rates,yet without accompanying measurable benefits in survival,performance,or quality of life. | Peter L Moses Khalid M AlNaamani Alan N Barkun Stuart R Gordon Roger D Mitty M Stanley Branch Thomas E Kowalski Myriam Martel Viviane Adam | 2013 | World Journal of Gastroenterology2013，19，46： | 6 |
| 3 | The Synthesis of a New Macrocyclic Dinucleating Ligand,3,6,9,17,20,23-Hexaaza-29,30-Dihydroxy-13,27-Dimethyl-Tricyclo[23,3,1,1^(11,15)]Triaconta-1(28),11,13, 15(30),25,26-Hexaene显示文摘A new dinucleating 24-membered hexaazadiphenol macrocyclic ligand, 3,6,9,17,20, 23-hexaaza-29,30- dihydroxy-13,27-dimethyl-tricycl [23, 3, 1, 1 11,15] triaconta -1(28), 11,13,15(30),25, 26-hexaene, BDBPH, was synthesized by the NaBH4 reduction of the Schiff-base obtained from the [2+2] condensation between diethylenetriamine and diformyl -p-cresol. The structure was characterized by elemental analysis, 1HNMR and FAB-MS. The synthetic method was also discussed. | Guo Qiang SHANGGUAN Arthur E. MARTELL Zhong Ren ZHANG (Department of Chemistry, Jining Medical College, Jining 272013Department of Chemistry, Texas A&M University, College Station, Texas 77842 USA) | 2000 | Chinese Chemical Letters2000，11，7： | 2 |
| 4 | Two-weight norm inequalities for maximal operators and fractionals on non-homogeneous spaces显示文摘 | Garcia-Cuerva J Martell J M | 2001 | Indiana Univ Math J2001，50，： | 2 |
| 5 | Future directions in myoma research显示文摘 | Brahma P K Martel K M Christman G M | 2006 | Obstet Gynecol Clin North Am2006，33，1： | 1 |
| 6 | Low blood lead levels associated with clinically diagnosed attention-deficit/ hyperactivity disorder and mediated by weak cognitive control 显示文摘 | NIGG J T KNOTTNERUS G M MARTEL M M | 2008 | Biol Psychiatry2008，63，3： | 1 |
| 7 | Effects of captopril related to increased levels of prostacyclin and angiotensin-(1 - 7) in essential hypertension显示文摘 | LUQUE M MARTIN P MARTELL N | 1996 | J Hypertension1996，14，： | 1 |
| 8 | Triple negative breast cancer: current understanding of biology and treatment options 显示文摘 | KANG S P MARTEL M HARRIS L N | 2008 | Curt Opin Obstet Gynecol2008，20，1： | 1 |
| 9 | Thermal behavior of Bombyx mori silk:evolution of crystalline parameters,molecular structure,and mechanical properties显示文摘 | Martel A Burghammer M Davies RJ | | 0，，11： | 1 |
| 10 | Effects of captopril related to increased levels of angiotensin-(1-7) in essential hypertension显示文摘 | Luque M Martin P Martell N | 1996 | Hypertension1996，14，： | 1 |
| 11 | Evolution of chloramphenicol resistance,with emergence of cross-resistance to florfenicol,in bovine Salmonella Typhimurium strains implicates definitive phage type (DT) 104显示文摘 | ARCANGIOLI M A LEROY-SETRIN S MARTEL J L | 2000 | J Med Microbiol2000，49，： | 1 |
| 12 | Hepatitis C virus(HCV)circulates as a population of different but closely related genomes:quasispecies nature of HCV genome distribution显示文摘 | Martell M Esteban J I Quer J | 1992 | J Virol1992，66，： | 1 |
| 13 | Promoting GHG mitigation policies for agriculture and forestry: a case study in Guadeloupe, French West Indies 显示文摘 | Colomb V Martel M Bockel L | 2014 | Land Use Policy2014，39，： | 1 |
| 14 | An index for tracking sheltered forest floor moisture within the Canadian Forest Fire Weather Index System显示文摘 | Wotton B M Stocks B J Martell D L | 2005 | International Journal of Wildland Fire2005，14，2： | 1 |
| 15 | Three-axis attitude determination via Kal- man filtering of magnetometer data显示文摘 | M L Psiaki F Martel | 1990 | Journal of Guidance Con- trol and Dynamics1990，13，3： | 1 |
| 16 | PROMETHEE-MD-2T method for project selection显示文摘 | Halouani N Chabchoub H Martel J M | 2009 | European Journal of Operational Research2009，195，： | 1 |
| 17 | Synthetic Plasmodiurn-like hemozoin activates the immune response: a morphologyfunction study 显示文摘 | Jaramillo M Bellemare MJ Martel C | 2009 | PLoS One2009，4，9： | 1 |
| 18 | Net- work Companies and Competitiveness: A Framework for Analysis 显示文摘 | LAKHAL S MARTEL A KETFANI O ORAL M | 1999 | European Journal of Operations Research1999，118，2： | 1 |
| 19 | Solving multi-criteria scheduling flow shop problem through compromise programming and satisfaction functions显示文摘 | Allouche M A Aouni B Martel J M el al | 2009 | European Journal of Operational Research2009，192，2： | 1 |
| 20 | Finishing of polyester fabrics with cyclodextrins and polycarboxylic acids as crosslinking agents显示文摘 | Martel B Moreellet M Ruffin D | 2002 | Incl Phenom Macro Chem2002，，44： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员